Murine mesenchymal cells that express elevated levels of the CDK inhibitor p16(Ink4a) in vivo are not necessarily senescent

Cell Cycle. 2017 Aug 18;16(16):1526-1533. doi: 10.1080/15384101.2017.1339850. Epub 2017 Jun 26.

Abstract

Age-related health decline has been attributed to the accumulation of senescent cells recognized in vivo by p16(Ink4a) expression. The pharmacological elimination of p16(Ink4a)-positive cells from the tissues of mice was shown to extend a healthy lifespan. Here, we describe a population of mesenchymal cells isolated from mice that are highly p16(INK4a)-positive are proficient in proliferation but lack other properties of cellular senescence. These data, along with earlier reports on p16(Ink4a)-positive macrophages, indicate that p16(Ink4a)-positive and senescent cell populations only partially intersect, therefore, extending the list of potential cellular targets for anti- aging therapies.

Keywords: biomarkers; healthspan; p16(Ink4a); senescence; senescence-associated β-galactosidase (SA-βGal).

MeSH terms

  • Animals
  • Cell Proliferation
  • Cellular Senescence*
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism*
  • Humans
  • Leukocyte Common Antigens / metabolism
  • Mesenchymal Stem Cells / cytology*
  • Mesenchymal Stem Cells / metabolism*
  • Mice, Inbred C57BL

Substances

  • Cyclin-Dependent Kinase Inhibitor p16
  • Leukocyte Common Antigens